COAVE THERAPEUTICS Trademark

Trademark Overview


On Thursday, December 30, 2021, a trademark application was filed for COAVE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the COAVE THERAPEUTICS trademark a serial number of 97197299. The federal status of this trademark filing is REGISTERED as of Tuesday, March 14, 2023. This trademark is owned by Coave Therapeutics. The COAVE THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations in the nature of viral systems, gene therapy systems, and nucleic acid delivery systems comprised of viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells used to deliver modified genetic material into other cells for medical purposes for the diagnosis, treatment or prevention of ophthalmological disorders, diseases of the central and peripheral nervous system, hereditary disorders, genetic disorders and disorders of monogenic origin; Pharmaceutical preparations and products in the nature of genetically modified cells for use in gene therapy for medical purposes; Pharmaceutical preparations, namely, vaccines, prophylactic pharmaceuticals in the nature of antigens, and other genetically modified pharmaceuticals cells or tissue for use in nucleic acid therapy, gene therapy and cell therapy; Drug delivery agents in the nature genetically modified compounds for medical, pharmaceutical or veterinary purposes; Biological tissue cultures for...

Product research and development in the fields of biotechnology, biology, biomedicine, pharmacy, medical sciences, gene therapy, chemistry and biochemistry; Biological, biomedical and pharmaceutical therapeutic research services; Research in the fields of pharmaceutical and biological therapeutic preparations, namely, gene therapy and nucleic acid delivery systems for use in clinical trials and post-marketing trials; Pharmaceutical research and development; Provision of scientific research information in the fields of pharmaceuticals, biomedicine, gene therapy, clinical trials and post-marketing trials; Biological research; Chemical analysis and research services; Providing medical and scientific research information in the field of clinical trials; conducting clinical trials for others; Medical research services
coave therapeutics

General Information


Serial Number97197299
Word MarkCOAVE THERAPEUTICS
Filing DateThursday, December 30, 2021
Status700 - REGISTERED
Status DateTuesday, March 14, 2023
Registration Number6999420
Registration DateTuesday, March 14, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 27, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations in the nature of viral systems, gene therapy systems, and nucleic acid delivery systems comprised of viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells used to deliver modified genetic material into other cells for medical purposes for the diagnosis, treatment or prevention of ophthalmological disorders, diseases of the central and peripheral nervous system, hereditary disorders, genetic disorders and disorders of monogenic origin; Pharmaceutical preparations and products in the nature of genetically modified cells for use in gene therapy for medical purposes; Pharmaceutical preparations, namely, vaccines, prophylactic pharmaceuticals in the nature of antigens, and other genetically modified pharmaceuticals cells or tissue for use in nucleic acid therapy, gene therapy and cell therapy; Drug delivery agents in the nature genetically modified compounds for medical, pharmaceutical or veterinary purposes; Biological tissue cultures for medical purposes; Chemical or biological reagents for medical, pharmaceutical or veterinary purposes, namely, for nucleic acid therapy, gene therapy and cell therapy; Biological preparations for medical, pharmaceutical or veterinary purposes, namely, for use in connection with medical and clinical gene therapy, nucleic acid therapy and cell therapy to diagnose, treat and prevent ophthalmological disorders, diseases of the central and peripheral nervous system, hereditary disorders, genetic disorders and disorders of monogenic origin
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesProduct research and development in the fields of biotechnology, biology, biomedicine, pharmacy, medical sciences, gene therapy, chemistry and biochemistry; Biological, biomedical and pharmaceutical therapeutic research services; Research in the fields of pharmaceutical and biological therapeutic preparations, namely, gene therapy and nucleic acid delivery systems for use in clinical trials and post-marketing trials; Pharmaceutical research and development; Provision of scientific research information in the fields of pharmaceuticals, biomedicine, gene therapy, clinical trials and post-marketing trials; Biological research; Chemical analysis and research services; Providing medical and scientific research information in the field of clinical trials; conducting clinical trials for others; Medical research services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 5, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 5, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCoave Therapeutics
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressParis 75012
FR

Party NameCoave Therapeutics
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressParis 75012
FR

Party NameCoave Therapeutics
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressParis 75012
FR

Trademark Events


Event DateEvent Description
Tuesday, March 14, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 14, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, December 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 27, 2022PUBLISHED FOR OPPOSITION
Wednesday, December 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 21, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 4, 2022NON-FINAL ACTION E-MAILED
Tuesday, October 4, 2022NON-FINAL ACTION WRITTEN
Tuesday, October 4, 2022ASSIGNED TO EXAMINER
Wednesday, January 5, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 3, 2022NEW APPLICATION ENTERED